NuSirt Biopharma launching new clinical trial

NuSirt BiopharmaNuSirt Biopharma, a company founded by Michael Zemel in Knoxville several years ago, has announced plans to launch a clinical trial to determine if its patented technology is a potential treatment for non-alcoholic fatty liver disease and steatohepatitis. The start-up, now based in Nashville, still maintains its research facilities here. For more information about the trial plans, read the news release. For our three-part series on the company, here are the links: Part 1, Part 2, and Part 3.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.